Phase II study: WBRT ±temozolomide (TMZ) in patients with multiple brain metastases from non-small cell lung cancer (NSCLC)

Category Primary study
JournalJournal of Clinical Oncology
Year 2009
This article has no abstract
Epistemonikos ID: cb96db5a8c18fe83308774cf89f4c17db53f46f0
First added on: Mar 01, 2025